5th ACE DRUG DISCOVERY SUMMIT
1st - 2nd May, 2025
THURSDAY - FRIDAY
AC Hotel Boston Downtown, USA
About 5th ADDS
5th ACE Drug Discovery Summit, 2025 provides a platform for scientists, researchers and decision makers from all over the world to debate on the latest scientific advances, trends, current challenges and futuristic advancements in Drug Discovery. The two day conference is designed to maximize collaborations and innovation with pharma and technology presentations, interactive sessions by professionals from industry and academia. The Summit features talks on the cutting edge of the discipline that include latest scientific advancements in the areas of drug discovery, AI, screening automation, high content imaging, disease modelling, cell and gene therapy and more. Summit will be attracting senior strategic decision-makers with top-level speakers, interactive round-tables, knowledge-sharing panel sessions, in-depth workshops and superb networking. Join us at 5th ACE Drug Discovery, 2025 to meet scientists from around the world and to learn how to move pharma from the bench to the market. We look forward to your contribution!
Why Attend
ADDS Thought Leaders
Kinkini Roy
Associate Director | Aviceda Therapeutics
Ana Vergara
Senior Scientist DMPK
| Merck
Michael Tolentino
Co-Founder, Board Member , Chief Innovation Officer | Aviceda Therapeutics
Shipra Malhotra
Senior Scientist, Biologics, Computational Biology / Machine Learning | Takeda
Jason Noon
Principal Research Scientist II, Head of Tissue Resident T cell Biology | AbbVie
Christin Glorioso
CEO & Co-founder |
NeuroAge Therapeutics
Dinesh Chandra
Associate Director |
Johnson & Johnson
Sundar Jubilant
Senior Scientist |
Arrakis Therapeutics
Tomi Sawyer
Chief Drug Hunter |
Maestro Therapeutics
Even Walseng
Director |
AstraZeneca
Zhinan Xia
CSO |
Abimmune Bio
Venkatesh Mysore
CTO |
Aikium Inc.
Anil Karihaloo
Sr Principal Res Scientist |
Novo Nordisk
Aridaman Pandit
Senior Principal Research Scientist, Head of Immune Profiling Centre, Head of Systems Immunology | ABBVIE
Lakshmi Kuttippurathu
Associate director, computational biology and data science | Lexicon Pharmaceuticals
Rajkumar Arumugam Rajasekaran
Senior Scientist |
Bristol Myers Squibb
Hariprasad Vankayalapati
Chief Scientific Officer |
Biolexis Therapeutics, Inc.
Alex Pellerin
Director |
Seismic Therapeutic
David Bearss
CEO |
Halia Therapeutics
Niyanta Kumar
Principal Research Scientist
I-DMPK | ABBVIE
Aftabul Haque
Principal Scientist
| Biogen
Igor Nasonkin
CEO |
Phythera Therapeutics
Nevin Gerek Ince
Director |
Novo Nordisk
Varnavas Mouchlis
Senior Scientist |
Bristol Myers Squibb
Vittal Shivva
Director & Distinguished Scientist | Genentech
Colles Price
Associate Director
| Takeda
Solutions at ADDS
🔷 Antibody Engineering
🔷 ADMUPI (Toxicology)
🔷 Covering Biological studies
🔷 Discovery Outsourcing Services
🔷 Drug Discovery Technology Platforms
🔷 High Throughput Screening
🔷 Licensing
🔷 ln licensing/out licensing discovery          projects proprietary technologies
🔷 PK/PD
🔷 Protein identification Services
🔷 Screening and Profiling Services
🔷 Transgenisis Services
🔷 Biochemistry
🔷 Biomarker Validation
🔷 Data Management Technology
🔷 DNA & RNA Analysis
🔷 Gene Expression Profiling Solutions
🔷 Lead Generation
🔷 lmaging/biomarker service/collaboration
🔷 Medicinal Chemistry
🔷 Pharmacogenetic Testing
🔷 Preclinical
🔷 Research & Development
🔷 Structural Biology
🔷 Bio-informatics
🔷 Combinatorial Chemistry
🔷 Digital lmaging Technology
🔷 DNA Sequencing Services
🔷 Genomics
🔷 Lead Optimatisation and Profiling, HTS       Technology
🔷 Molecular Biology
🔷 Pharmacology
🔷 Principal Scientists
🔷 Reagents Technology
🔷 Target identification & Validation
Who Will Attend
🔷 CEO
🔷 Director of Discovery Strategy Portfolio
🔷 Head of DMPK
🔷 Head of R&D Licensing
🔷 Senior Director Discovery Research
🔷 VP of Chemistry
🔷 VP Translational Medicine
🔷 CSO
🔷 Head Pharmacology & Toxicology
🔷 Head of Drug Design
🔷 Head Pharmacology & Toxicology
🔷 Senior Director Function Genomics
🔷Director of Screening & Compound Profiling
🔷 Director Discovery Alliances
🔷 Executive Director Chemistry
🔷 Head of Molecular Toxicology
🔷 Principal Scientist
🔷 VP & Director of Drug Discovery
🔷 VP Target Discovery & Assessment
Attendee Breakdown
Attendee Demographics
Agenda
🔷 08:45 – 09:00 Chairman’s Welcome Remarks
🔷 09:00 – 09:30 Presentation no.1:
Artificial Intelligence in Revolutionizing Drug Discovery:
- AI assistance to pharma industries helps to improve overall life cycle of product
- AI can be implemented in pharma ranging from drug discovery to product management
- Future challenges related to AI and their respective solutions have been expounded
Buyers 2025 Pharma / Biotech
Our Sponsors
Our Partners
Media Partners
Venue - AC Hotel Boston Downtown
Located in the heart of Boston, MA, AC Hotel Boston Downtown bridges the city’s rich past and vibrant present. Positioned near Tufts Medical Center, the hotel offers a harmonious blend of thoughtful service and modern amenities tailored for travelers. Guests can enjoy European-inspired breakfasts, complimentary WiFi, spacious 50-inch TVs, flexible workspaces, and mini-fridges.
Additional offerings include a 24-hour fitness center, business services, and versatile meeting spaces for 5 to 80 guests. Visitors can savor tapas-inspired bites in the AC Lounge or find quick snacks in the AC Store. Perfect for immersing yourself in Boston’s dynamic energy, the hotel provides easy access to cultural attractions, theaters, universities, convention centers, and the airport. It’s also an ideal choice for group wedding blocks near The Cathedral of The Holy Cross.
SPONSORSHIP OPPORTUNITIES
If you wish to inquire about sponsorship prospects, kindly reach out to:
SPEAKER / DELEGATE OPPORTUNITIES
If you wish to inquire about speaking opportunities, and to book attendee pass, kindly reach out to:
